MEDIROM Healthcare Technologies Gross Profit

The latest gross profit for MRM is $2.9B as of December 2025. That compares with $26M in the prior-year period — up 11103.1% year over year. That is below the Consumer Discretionary sector average of $360B. Investors often review this figure alongside MEDIROM Healthcare Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, MRM's gross profit moved from $26M to $2.9B — a 11103.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MEDIROM Healthcare Technologies's operating scale or balance-sheet position.

Against Consumer Discretionary companies, MRM currently prints $2.9B for gross profit, while the sector average sits near $360B. That is roughly 99.2% below the sector mean. Large gaps often invite a closer look at MEDIROM Healthcare Technologies's growth, margins, and balance sheet.

A gross profit figure of $2.9B for MRM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $360B. Explore the charts below for those layers of context.

After noting MRM's gross profit ($2.9B), review year-over-year change from $26M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.